Several other brokerages also recently issued reports on UDG. Peel Hunt upped their price target on shares of Udg Healthcare from GBX 840 ($11.78) to GBX 860 ($12.06) and gave the company an add rating in a report on Tuesday, October 31st. Numis Securities downgraded shares of Udg Healthcare to a reduce rating and set a GBX 765 ($10.73) price target on the stock. in a report on Thursday, November 9th. Liberum Capital reaffirmed a hold rating and issued a GBX 884 ($12.39) price target on shares of Udg Healthcare in a report on Wednesday, November 15th. Jefferies Group reduced their price target on shares of Udg Healthcare from GBX 855 ($11.99) to GBX 800 ($11.22) and set a hold rating on the stock in a report on Monday, December 4th. Finally, Stifel Nicolaus reaffirmed a hold rating and issued a GBX 815 ($11.43) price target on shares of Udg Healthcare in a report on Thursday, November 30th. One analyst has rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company. Udg Healthcare currently has a consensus rating of Hold and a consensus price target of GBX 832.63 ($11.67).
Shares of Udg Healthcare (LON UDG) opened at GBX 782.50 ($10.97) on Wednesday. Udg Healthcare has a fifty-two week low of GBX 646.50 ($9.06) and a fifty-two week high of GBX 963 ($13.50). The stock has a market cap of $1,950.00 and a PE ratio of 3,726.19.
Udg Healthcare Company Profile
UDG Healthcare PLC, formerly United Drug PLC, provides advisory, commercial, clinical, communications and packaging services to the healthcare industry with operations in approximately 24 countries and delivering services in over 50 countries. The Company operates across three divisions: Ashfield, which provides commercialization services for the pharmaceutical and healthcare industry and operates across two areas of activity: advisory & communications services and commercial & clinical services and provides healthcare communications, patient support, audit, advisory, medical information and event management services; Sharp, which provides contract commercial packaging and clinical trial packaging services for the pharmaceutical and biotechnology industries and operates facilities in the United States and Europe; and Aquilant, which provides outsourced sales, marketing, distribution and engineering services to the medical and scientific sectors in the UK, Ireland and the Netherlands.
Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.